Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
39.7M
-
Shares change
-
-5.54M
-
Total reported value, excl. options
-
$349M
-
Value change
-
-$60.9M
-
Put/Call ratio
-
0.11
-
Number of buys
-
42
-
Number of sells
-
-74
-
Price
-
$8.78
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q3 2021
163 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.7M shares
of 60M outstanding shares and own 66.17% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.9M shares), STATE STREET CORP (3.43M shares), BlackRock Inc. (3.26M shares), First Light Asset Management, LLC (2.99M shares), VANGUARD GROUP INC (2.73M shares), Woodline Partners LP (2.1M shares), EAGLE ASSET MANAGEMENT INC (1.35M shares), FMR LLC (1.2M shares), GEODE CAPITAL MANAGEMENT, LLC (902K shares), and Altium Capital Management LP (864K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.